Peptide directory

Search by name, filter by evidence, and open any peptide for its graded studies and regulatory status, sourced to primary documents. Research information only.

Sort

7 / 7

BPC-157 Human trial

Animal evidence only. Not approved anywhere. Up for an FDA advisory committee vote on July 23, 2026. Banned for athletes (WADA S0) since 2022.

89 studies 2 trials FDA 2026-07-23
DSIP Human RCT

Research peptide, not approved for human use anywhere. Up for an FDA advisory committee vote on July 24, 2026 (evaluated indication: Opioid withdrawal, chronic insomnia, narcolepsy). Removed from the FDA 'do not compound' list in April 2026 but not yet compoundable.

86 studies FDA 2026-07-24
Epitalon Human trial

Research peptide, not approved for human use anywhere. Up for an FDA advisory committee vote on July 24, 2026 (evaluated indication: Insomnia). Removed from the FDA 'do not compound' list in April 2026 but not yet compoundable.

88 studies FDA 2026-07-24
KPV Human RCT

Research peptide, not approved for human use anywhere. Up for an FDA advisory committee vote on July 23, 2026 (evaluated indication: Wound healing and inflammatory conditions). Removed from the FDA 'do not compound' list in April 2026 but not yet compoundable.

92 studies FDA 2026-07-23
MOTS-c Human RCT

Research peptide, not approved for human use anywhere. Up for an FDA advisory committee vote on July 23, 2026 (evaluated indication: Obesity and osteoporosis). Removed from the FDA 'do not compound' list in April 2026 but not yet compoundable.

88 studies 4 trials FDA 2026-07-23
Semax Human RCT

Research peptide, not approved for human use anywhere. Up for an FDA advisory committee vote on July 24, 2026 (evaluated indication: Cerebral ischemia, migraine, trigeminal neuralgia). Removed from the FDA 'do not compound' list in April 2026 but not yet compoundable.

58 studies FDA 2026-07-24
TB-500 Human trial

Research peptide, not approved for human use anywhere. Up for an FDA advisory committee vote on July 23, 2026 (evaluated indication: Wound healing). Removed from the FDA 'do not compound' list in April 2026 but not yet compoundable.

100 studies 1 trials FDA 2026-07-23